Olanzapine/Fluoxetine (Symbyax) for bipolar depression
Medical Letter on Drugs and Therapeutics 46(1178): 23-24
2004
ISSN/ISBN: 0025-732X PMID: 15037858 Document Number: 578202
Document emailed within 1 workday
Related Documents
Koszewska, I. 1996: Pharmacotherapy of depression in patients with and without conversion from depression to mania in the course of bipolar affective disorder Psychiatria Polska 30(1): 99-111Rothschild, A.J.; Bates, K.S.; Boehringer, K.L.; Syed, A. 1999: Olanzapine response in psychotic depression Journal of Clinical Psychiatry 60(2): 116-118
Montgomery, S.A.; Dufour, H.; Brion, S.; Gailledreau, J.; Laqueille, X.; Ferrey, G.; Moron, P.; Parant-Lucena, N.; Singer, L.; Danion, J.M. 1988: The prophylactic efficacy of fluoxetine in unipolar depression British Journal of Psychiatry. Suppl 3: 69-76
Straton, J.B.; Cronholm, P. 2002: Are paroxetine, fluoxetine, and sertraline equally effective for depression? Journal of Family Practice 51(3): 285
Ginestet, D. 1989: Fluoxetine in endogenous depression and melancholia versus clomipramine International Clinical Psychopharmacology 4(Suppl 1): 37-40
Sheikha, S.H.; Wagner, K.D.; Wagner, R.F. 1993: Fluoxetine treatment of trichotillomania and depression in a prepubertal child Cutis 51(1): 50-52
Levine, S.; Anderson, D.; Bystritsky, A.; Baron, D. 1990: A report of eight HIV-seropositive patients with major depression responding to fluoxetine Journal of Acquired Immune Deficiency Syndromes 3(11): 1074-1077
McGrath, P.J.; Stewart, J.W.; Petkova, E.; Quitkin, F.M.; Amsterdam, J.D.; Fawcett, J.; Reimherr, F.W.; Rosenbaum, J.F.; Beasley, C.M. 2000: Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression Journal of Clinical Psychiatry 61(7): 518-524
Bennie, E.H.; Mullin, J.M.; Martindale, J.J. 1995: A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression Journal of Clinical Psychiatry 56(6): 229-237
Dalery, J.; Bouhassira, M.; Kress, J.P.; Lancrenon, S.; Tafani, A.; Hantouche, E.G. 1995: Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine L'Encephale 21(3): 217-225
Haslemo, T.; Refsum, H.; Molden, E. 2011: The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine British Journal of Clinical Pharmacology 71(4): 611-615
Post, R.M. 2005: The impact of bipolar depression Journal of Clinical Psychiatry 66(Suppl 5): 5-10
Goodnick, P.J.; Fieve, R.R.; Peselow, E.D.; Barouche, F.; Schlegel, A. 1987: Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGi change Psychopharmacology Bulletin 23(1): 162-163
Benazzi, F. 1999: Bipolar Ii and unipolar atypical depression Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(10): 1050-1051
Grunze, H. 2005: Reevaluating therapies for bipolar depression Journal of Clinical Psychiatry 66(Suppl 5): 17-25
Ostacher, M.J. 2006: The evidence for antidepressant use in bipolar depression Journal of Clinical Psychiatry 67(Suppl 11): 18-21
Keck, P.E.; McElroy, S.L. 2003: New approaches in managing bipolar depression Journal of Clinical Psychiatry 64(Suppl 1): 13-18
Spasojevic, N.; Jovanovic, P.; Dronjak, S. 2012: Chronic fluoxetine treatment affects gene expression of catecholamine enzymes in the heart of depression model rats Indian Journal of Experimental Biology 50(11): 771-775
Ukaegbu, C.; Banks, J.B.; Carter, N.J.; Goldman, L.S. 2008: Clinical inquiries: what drugs are best for bipolar depression? Journal of Family Practice 57(9): 606-608
Beasley, C.M.; Nilsson, M.E.; Koke, S.C.; Gonzales, J.S. 2000: Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose Journal of Clinical Psychiatry 61(10): 722-728